NAMS logo

NAMS EBITDA

Annual EBITDA

-$241.49 M
-$64.63 M-36.54%

December 31, 2024


Summary


Performance

NAMS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAMSprofitabilitymetrics:

Quarterly EBITDA

-$111.69 M
-$87.85 M-368.51%

December 31, 2024


Summary


Performance

NAMS Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAMSprofitabilitymetrics:

TTM EBITDA

-$241.49 M
-$60.71 M-33.58%

December 31, 2024


Summary


Performance

NAMS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAMSprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

NAMS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-36.5%-368.5%-33.6%
3 y3 years-483.7%-368.5%-33.6%
5 y5 years-3533.2%-368.5%-33.6%

NAMS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-981.0%at low-368.5%at low-525.3%at low
5 y5-year-3533.2%at low-368.5%at low-525.3%at low
alltimeall time-3533.2%at low-368.5%at low-525.3%at low

NewAmsterdam Pharma Company NV EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$241.49 M(+36.5%)
-$111.69 M(+368.5%)
-$241.49 M(+33.6%)
Sep 2024
-
-$23.84 M(-53.6%)
-$180.78 M(-11.9%)
Jun 2024
-
-$51.38 M(-5.9%)
-$205.21 M(+6.4%)
Mar 2024
-
-$54.57 M(+7.0%)
-$192.82 M(+9.0%)
Dec 2023
-$176.86 M
-$50.99 M(+5.6%)
-$176.86 M(+40.5%)
DateAnnualQuarterlyTTM
Sep 2023
-
-$48.27 M(+23.8%)
-$125.87 M(+62.2%)
Jun 2023
-
-$38.99 M(+1.0%)
-$77.61 M(+101.0%)
Mar 2023
-
-$38.62 M
-$38.62 M
Dec 2022
-$22.34 M(-46.0%)
-
-
Dec 2021
-$41.37 M(+522.4%)
-
-
Dec 2020
-$6.65 M
-
-

FAQ

  • What is NewAmsterdam Pharma Company NV annual EBITDA?
  • What is the all time high annual EBITDA for NewAmsterdam Pharma Company NV?
  • What is NewAmsterdam Pharma Company NV annual EBITDA year-on-year change?
  • What is NewAmsterdam Pharma Company NV quarterly EBITDA?
  • What is the all time high quarterly EBITDA for NewAmsterdam Pharma Company NV?
  • What is NewAmsterdam Pharma Company NV quarterly EBITDA year-on-year change?
  • What is NewAmsterdam Pharma Company NV TTM EBITDA?
  • What is the all time high TTM EBITDA for NewAmsterdam Pharma Company NV?
  • What is NewAmsterdam Pharma Company NV TTM EBITDA year-on-year change?

What is NewAmsterdam Pharma Company NV annual EBITDA?

The current annual EBITDA of NAMS is -$241.49 M

What is the all time high annual EBITDA for NewAmsterdam Pharma Company NV?

NewAmsterdam Pharma Company NV all-time high annual EBITDA is -$6.65 M

What is NewAmsterdam Pharma Company NV annual EBITDA year-on-year change?

Over the past year, NAMS annual EBITDA has changed by -$64.63 M (-36.54%)

What is NewAmsterdam Pharma Company NV quarterly EBITDA?

The current quarterly EBITDA of NAMS is -$111.69 M

What is the all time high quarterly EBITDA for NewAmsterdam Pharma Company NV?

NewAmsterdam Pharma Company NV all-time high quarterly EBITDA is -$23.84 M

What is NewAmsterdam Pharma Company NV quarterly EBITDA year-on-year change?

Over the past year, NAMS quarterly EBITDA has changed by -$87.85 M (-368.51%)

What is NewAmsterdam Pharma Company NV TTM EBITDA?

The current TTM EBITDA of NAMS is -$241.49 M

What is the all time high TTM EBITDA for NewAmsterdam Pharma Company NV?

NewAmsterdam Pharma Company NV all-time high TTM EBITDA is -$38.62 M

What is NewAmsterdam Pharma Company NV TTM EBITDA year-on-year change?

Over the past year, NAMS TTM EBITDA has changed by -$60.71 M (-33.58%)